FOR THE FIRST TIME, CAR-T-THERAPY WAS APPLIED AT P. HERTSEN MORI
On October 1, 2025, CAR-T therapy using anti-CD19 CAR-T, a Russian individualized biomedical cellular product, was performed at the P. Hertsen Moscow Oncology Research Institute – the branch of the National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation for the first time.The first patient to receive innovative treatment was a man diagnosed with...











